0000000000054712

AUTHOR

Maurizio Rossini

0000-0001-9692-2293

showing 5 related works from this author

The burden of previous fractures in hip fracture patients. The Break Study

2011

A positive history of fractures in older patients with hip fracture is common. We determined the risk factors associated with a positive history of fractures and the profile of care in hip fracture patients. In the Break Study, we enrolled 1249 women aged ≥60 years, seeking care for a hip fracture. Baseline information included age, body mass index, lifestyle (smoking habit, alcohol consumption), patient's history of fracture after the age of 50 years, family history of fragility fracture and health status (presence of comorbidity, use of specific drugs, pre-fracture walking ability, type of fracture, time to surgery, type of surgery, osteoporosis treatment). In the multivariable model age,…

Multiple fractureAgingPediatricsmedicine.medical_specialtyMultivariate analysisCross-sectional studyOsteoporosisPsychological interventionHip fractureBody Mass IndexRisk Factorship fractures; care; osteoporosismedicineHumanscareFamily historyAgedAged 80 and overHip fractureProfile of carebusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaMiddle Agedmedicine.diseaseosteoporosisComorbidityCross-Sectional StudiesHip fracture Break studyhip fracturesMultivariate AnalysisPhysical therapyFemaleGeriatrics and GerontologybusinessDelivery of Health CareBody mass indexAging Clinical and Experimental Research
researchProduct

Erratum to: The burden of previuos fractures in hip fracture patients. The Break Study

2011

Agingmedicine.medical_specialtyHip fracturebusiness.industryGeriatrics gerontologyPhysical therapyMedicineGeriatrics and Gerontologybusinessmedicine.diseaseAging Clinical and Experimental Research
researchProduct

Osteoporosis: Economic Burden of Disease in Italy.

2020

Background and Objective: Today, osteoporosis is the most common bone disease and an important public health problem in all developed countries. The objective of this study was to estimate the costs associated with the management and treatment of osteoporosis in order to assess the economic burden in Italy for 2017, in terms of direct medical costs and social security costs. Methods: A cost of illness model was developed to estimate the average cost per year sustained by the NHS (National Health Service) and Social Security System in Italy. A systematic literature review was performed to obtain epidemiological, direct and indirect costs parameters where available. Hospitalisation costs were…

Patient Discharge.Malemedicine.medical_specialtySettore SECS-P/06accountingalliedhealth030204 cardiovascular system & hematology030226 pharmacology & pharmacyState MedicineServizio Sanitario Nazionale03 medical and health sciencesIndirect costs0302 clinical medicineCost of IllnessInternational Classification of DiseasesEnvironmental healthEpidemiologyInternational Classification of DiseasemedicineHumansPharmacology (medical)health care economics and organizationsAverage costAgedPensionbusiness.industryPublic healthOsteoporosieconomicsAged; Female; Health Care Costs; Hospitalization; Humans; International Classification of Diseases; Italy; Male; Middle Aged; Osteoporosis; Patient Discharge; State Medicine; Cost of IllnessGeneral MedicineHealth Care Costsosteoporosi Italia Servizio Sanitario NazionaleMiddle AgedItaliaPatient DischargeHealth Care CostSocial securityHospitalizationSystematic reviewItalySettore MED/42OsteoporosisFemalebusinessDeveloped countryHumanClinical drug investigation
researchProduct

Low vitamin K1 intake in haemodialysis patients

2017

Background & aims Vitamin K acts as a coenzyme in the γ-carboxylation of vitamin K-dependent proteins, including coagulation factors, osteocalcin, matrix Gla protein (MGP), and the growth arrest-specific 6 (GAS6) protein. Osteocalcin is a key factor for bone matrix formation. MGP is a local inhibitor of soft tissue calcification. GAS6 activity prevents the apoptosis of vascular smooth muscle cells. Few data on vitamin K intake in chronic kidney disease patients and no data in patients on a Mediterranean diet are available. In the present study, we evaluate the dietary intake of vitamin K1 in a cohort of patients undergoing haemodialysis. Methods In this multi-centre controlled observati…

Malemedicine.medical_treatment030232 urology & nephrology030204 cardiovascular system & hematologyRecommended Dietary AllowancesCritical Care and Intensive Care Medicinenot knownBody Mass Indexchemistry.chemical_compound0302 clinical medicineMatrix gla proteinPrevalenceMicronutrientsNutrition and DieteticsbiologyVitamin K 1Middle AgedMicronutrientHaemodialysisOsteocalcinDialysis; Diet; Haemodialysis; Menaquinone; Nutrition; PhylloquinoneFemaleDietary ProteinsWaist CircumferenceMenaquinoneDialysis; Diet; Haemodialysis; Menaquinone; Nutrition; Phylloquinone; Nutrition and Dietetics; Critical Care and Intensive Care MedicineVitaminmedicine.medical_specialtyNutritional Status03 medical and health sciencesRenal DialysisPhylloquinoneInternal medicineVitamin K deficiencyDietary CarbohydratesmedicineHumansVitamin B12Renal Insufficiency ChronicDialysisAgedRetrospective StudiesNutritionbusiness.industrymedicine.diseaseDietary FatsDietNutrition AssessmentEndocrinologychemistryCase-Control Studiesbiology.proteinVitamin K DeficiencybusinessDialysisCalcification
researchProduct

Guidelines for the management of osteoporosis and fragility fractures

2018

The purpose of this document, a result of the harmonisation and revision of Guidelines published separately by the SIMFER, SIOMMMS/SIR, and SIOT associations, is to provide practical indications based on specific levels of evidence and various grades of recommendations, drawn from available literature, for the management of osteoporosis and for the diagnosis, prevention, and treatment of fragility fractures. These indications were discussed and formally approved by the delegates of the Italian Scientific Associations involved in the project (SIE, SIGG, SIMFER, SIMG, SIMI, SIOMMMS, SIR, and SIOT). The purpose of this document, a result of the harmonisation and revision of Guidelines publishe…

medicine.medical_specialtyBone densityOsteoporosis030204 cardiovascular system & hematologyEM - Original03 medical and health sciences0302 clinical medicineFragilityBone DensitymedicineSettore MED/33 - Malattie Apparato LocomotoreInternal MedicineHumans030212 general & internal medicineFractures; Osteoporosis; Therapy; Internal Medicine; Emergency Medicinebusiness.industryOsteoporosiEvidence-based medicinemedicine.diseaseFractures; Osteoporosis; TherapyFractureItalyFamily medicineEmergency MedicineOsteoporosisTherapybusinessFracturesOsteoporotic Fractures
researchProduct